Health Catalyst, Inc. (HCAT)
1.60
+0.07
(+4.58%)
USD |
NASDAQ |
Aug 24, 16:00
1.60
0.00 (0.00%)
After-Hours: 20:00
Health Catalyst Profit Margin (Quarterly) : -57.51% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -57.51% |
| March 31, 2026 | -156.9% |
| December 31, 2025 | -121.9% |
| September 30, 2025 | -29.12% |
| June 30, 2025 | -50.76% |
| March 31, 2025 | -29.90% |
| December 31, 2024 | -25.97% |
| September 30, 2024 | -19.29% |
| June 30, 2024 | -17.81% |
| March 31, 2024 | -27.55% |
| December 31, 2023 | -40.37% |
| September 30, 2023 | -29.86% |
| June 30, 2023 | -44.55% |
| March 31, 2023 | -44.93% |
| December 31, 2022 | -51.74% |
| September 30, 2022 | -66.91% |
| June 30, 2022 | -47.33% |
| March 31, 2022 | -32.98% |
| December 31, 2021 | -75.70% |
| Date | Value |
|---|---|
| September 30, 2021 | -64.81% |
| June 30, 2021 | -60.10% |
| March 31, 2021 | -50.80% |
| December 31, 2020 | -80.74% |
| September 30, 2020 | -57.91% |
| June 30, 2020 | -62.84% |
| March 31, 2020 | -38.77% |
| December 31, 2019 | -32.79% |
| September 30, 2019 | -54.32% |
| June 30, 2019 | -29.06% |
| March 31, 2019 | -38.96% |
| December 31, 2018 | -37.62% |
| September 30, 2018 | -51.34% |
| June 30, 2018 | -84.05% |
| March 31, 2018 | -59.18% |
| December 31, 2017 | -32.57% |
| September 30, 2017 | -75.91% |
| June 30, 2017 | -74.59% |
| March 31, 2017 | -82.67% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| LataMed AI Corp. | -- |
| SCWorx Corp. | -17.14% |
| GoodRx Holdings, Inc. | 4.26% |
| Claritev Corp. | -23.00% |
| iSpecimen, Inc. | -897.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -113.7% |
| Return on Assets | -53.46% |
| Return on Invested Capital | -65.52% |
| Gross Profit Margin (Quarterly) | 34.67% |
| Operating Margin (Quarterly) | -5.35% |
| Return on Net Operating Assets | -73.15% |